Clostridium Difficile Treatment: Focus on the New Guidelines

Dr. Mercurio, an ID Clinical Pharmacy Specialist at the James A Haley Veterans Hospital, presents an update on Clostridium Difficile infection (CDI). Dr. Mercurio begins by sharing a timeline of the history of C difficile treatment. She then reviews the epidemiology of this common hospital pathogen. Next, she discusses the clinical definition of CDI. Dr. Mercurio next relates changes to the c difficile recommendations in the 2017 and 2021 guidelines. Finally, she discusses later generation treatments including Fidaxomicin and Bezlotoxumab. From a presentation recorded in August 2021.